To compare two drugs for uterine contraction in patients undergoing Caesarean sectio
Phase 3
- Conditions
- Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
- Registration Number
- CTRI/2024/07/069904
- Lead Sponsor
- Dr Vanshika Saranga
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anaethesiologists physical status II
Patients undergoing elective caesarean section under subarachnoid block
provides consent
Exclusion Criteria
Presence of hypertension,preeclampsia,cardiac,renal or liver diseases, epilepsy and dearranged coagulation profile
patients undergoing general anaesthesia and emergency LSCS
patient who are unable or unwilling to give consent
women with history of hypersensitivity to carbetocin
patients who do not fulfil inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the maternal hemodynamic changes for oxytocin and carbetocin(effect on heart rate and blood pressure)during elective Caesarean sectionTimepoint: 0min,3min,6min,9min,12min,15min,18min,21min,24min,27min,30min,33min,36min,39min,42min,45min
- Secondary Outcome Measures
Name Time Method To assess the effective uterotonic action of oxytocin & carbetocin in terms of estimation of preoperative & postoperative HB estimationTimepoint: 48hours after delivery